Nephrotoxicity of hydroalcoholic extract of Teucrium polium in Wistar rats

Pakistan Journal of Medical Sciences

Volumn 29, Issue 1 SUPPL., 2013, Pages 329-333

  Baradaran, Azar ^a   Madihi, Yahya ^b   Merrikhi, Alireza ^b   Rafieian Kopaei, Mahmoud ^c   Nematbakhsh, Mehdi ^a   Asgari, Azam ^c   Khosravi, Zahra ^c   Haghighian, Farshad ^c   Nasri, Hamid ^c  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHREKORD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Nephrotoxicity; Teucrium polium; Tubular cell degeneration; Tubular cells

Indexed keywords

TEUCRIUM POLIUM EXTRACT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEGENERATION; CELL VACUOLE; CONTROLLED STUDY; CONVALESCENCE; DISEASE SEVERITY; DRUG SCREENING; KIDNEY INJURY; KIDNEY TUBULE CELL; KIDNEY TUBULE DISORDER; MALE; MEDICINAL PLANT; NEPHROTOXICITY; NONHUMAN; PLANT LEAF; RAT; TEUCRIUM POLIUM; TISSUE REGENERATION; WISTAR RAT;

EID: 84874742592     PISSN: 1682024X     EISSN: None     Source Type: Journal    
DOI: 10.12669/pjms.291(Suppl).3527     Document Type: Article

References (57)

1. Rizk AM, Hammouda FM, Rimpler H, Kamel A. Iridoids and flavonoids of Teucrium polium herb. Planta Med. 1986;52:87-88.
2. Khajehdehi P. Turmeric: Reemerging of a neglected Asian traditional remedy. J Nephropathology. 2012;1(1):17-22.
3. Rahimi Z. ACE insertion/deletion (I/D) polymorphism and diabetic nephropathy. J Nephropathology. 2012;1(3):143-151.
4. Ljubuncic P, Dakwar S, Portnaya I, Cogan U, Azaizeh H, Bomzon A. Aqueous extracts of Teucrium polium possess remarkable antioxidant activity in vitro. Evid Based Complement Alternat Med. 2006;3(3):329-338.
5. Solati M, Mahboobi HR. Paraoxonase enzyme activity and dyslipidemia in chronic renal failure patients. J Nephropathology. 2012;1(3):123-125.
6. Baradaran A. Lipoprotein (a), type 2 diabetes and nephropathy; the mystery continues. J Nephropathology. 2012;1(3):126-129.
7. Ardestani A, Yazdanparast R, Jamshidi SH. Therapeutic effects of Teucrium polium extract on oxidative stress in pancreas of streptozotocin-induced diabetic rats. J Med Food. 2008;11(3):525-532.
8. Kari J. Epidemiology of chronic renal failure in children. J Nephropathology. 2012;1(3):162-163.
9. Talal A, Mohammad H, Vanni C. Composition of the Essential Oil from Jordanian Germander (Teucrium polium L.). J Essent Oil Res. 2006;8:97-99.
10. Cakir A, Emin Dum M, Harmandar M. Volatile constituents of Teucrium polium L. from Turkey. J Essent Oil Res. 1998;10:113-155.
11. Vokou D, Bessiere JM. Volatile constituents of Teucriumpolium. J Nat Prod. 1985;48:498-499.
12. Autore G, Capasso F, De Fusco R, Fasulo MP, Lembo M, Mascolo N. Antipyretic and antibacterial actions of Teucriumpolium. Pharmacol. Res Commun. 1984;16:21-29.
13. Tariq M, Ageel AM, Al-Yahya MA, Mossa JS, Al-Said MS. Antiinflammatory activity of Teucriumpolium. Int J Tissue React. 1986;11:185-188.
14. Kadifkova Panovska T, Kulevanov S, Stefov M. In vitro antioxidant activity of some Teucrium species (Lamiaceae). Acta Pharm. 2005;55:207-214.
15. Ljubuncic P, Dakwar S, Portnaya I, Cogan U, Azaizeh H, Bomzon A. Aqueous Extracts of Teucrium polium Possess Remarkable Antioxidant Activity in Vitro. Evid Based Complement Alternat Med. 2006;3:329-338.
16. Alkofahi A, Atta AH. Pharmacological screening of the antiulcerogenic effects of some Jordanian medicinal plants in rats. J Ethnopharmacol. 1999;67:341-345.
17. Galati EM, Mondello MR, D'Aquino A, Miceli N, Sanogo R, Tzakou O. Effects of Teucrium divaricatum Heldr. ssp. divaricatum decoction on experimental ulcer in rats. J Ethnopharmacol. 2000;72:337-342.
18. Abdollahi M, Karimpour H, Monsef-Esfehani HR. Antinociceptive effects of Teucrium polium L. total extract and essential oil in mouse writhing test. Pharmacol Res. 2003;48:31.
19. Baluchnejadmojarad T, Roghani M, Roghani-Dehkordi F. Antinociceptive effects of Teucrium polium leaf extract in the diabetic rat formalin test. J Ethnopharmacol. 2005;97:207-210.
20. Gharaibeh NMN, Elayan HE, Salhab AS. Hypoglycemic effects of Teucriumpolium. J Ethnopharmacol. 1988;24:93-99.
21. Yazdanparast R, Esmaeili MA, Ashrafi J. Teucrium polium extract effects pancreatic function of streptozotocin diabetic rats: A histopathological examination. Iran Biomed J. 2005;9:81-85.
22. Parsaee H, Shafiee-Nick R. Anti-Spasmodic and Antinociceptive effects of Teucrium polium aqueous extract. Iran Biomed J. 2006;10:145-149.
23. Suleiman MS, Abdul-Ghani AS, Al-Khalil S, Amir R. Effect of Teucrium polium boiled leaf extract on intestinal motility and blood pressure. J Ethnopharmacol. 1988;22:111-116.
24. Sadraei H, Hajhashemi V, Ghannad A, Mohseni M. Antispasmodic effect of aerial part of Teucrium polium L. essential oil on rat isolated ileum in vitro. Med J Islam Rep Iran. 2001;14:355-358.
25. Rasekh HR, Khoshnood-Mansourkhani MJ, Kamalinejad M. Hypolipidemic effects of Teucrium polium in rats. Fitohterapia. 2001;72:937-939.
26. Shahraki MR, Arab MR, Mirimokaddam E, Palan MJ. The effect of Teucrium polium (Calpoureh) on liver function, serum lipids and glucose in diabetic male rats. Iran Biomed J. 2007;11:65-68.
27. Niazmand S, Erfanian Ahmadpoor M, Moosavian M, Derakhshan M. The positive inotropic and chronotropic effects of Teucrium polium L. extract on Guinea pig isolated heart. Pharmacol online. 2008;2:588-594. Dup on Ref. 28
28. Abu Sitta KH, Shomah MS, Salhab AS. Hepatotoxicity of Teucrium polium L. tea: supporting evidence in mice models. Aust J Med Herbal. 2009;21:106-109.
29. Rasekh HR, Khoshnood-Mansourkhani MJ, Kamalinejad M. Hypolipidemic effects of Teucrium polium in rats. Fitoterapia. 2001;72:937-939.
30. Rafieian-Kopaei M, Nasri H, Nematbakhsh M, Baradaran A, Gheissari A, Rouhi H. Erythropoietin ameliorates genetamycininduced renal toxicity: A biochemical and histopathological study. J Nephropathology. 2012;1(2):109-116.
31. Amini FG, Rafieian-Kopaei M, Nematbakhsh M, Baradaran A, Nasri H. Ameliorative effects of metformin on renal histologic and biochemical alterations of gentamicin-induced renal toxicity in Wistar rats. J Res Med Sci. 2012;17:621-625.
32. Nematbakhsh M, Ashrafi F, Pezeshki Z, Fatahi Z, Kianpoor F, Sanei MH. A histopathological study of nephrotoxicity, hepatoxicity or testicular toxicity: Which one is the first observation as side effect of Cisplatin induced toxicity in animal model. J Nephropathology. 2012;1(3):190-193.
33. Tavafi M. Inhibition of gentamicin-induced renal tubular cell necrosis. J Nephropathology. 2012;1(2):83-86.
34. Kadkhodaee M. Erythropoietin; bright future and new hopes for an old drug. J Nephropathology. 2012;(2):81-82.
35. Ardalan MR, Samadifar Z, Vahedi A. Creatine monohydrate supplement induced interstitial nephritis. J Nephropathology. 2012;1(2):117-120.
36. Mattei A, Rucay P, Samuel D, Feray C, Reynes M, Bismuth H. Liver transplantation for severe acute liver failure after herbal medicine (Teucriumpolium) administration. J Hepatol. 1995;22:597.
37. Polymeros D, Kamberoglou D, Tzias V Acute cholestatic hepatitis caused by Teucrium polium (golden germander) with transient appearance of anti mitochondrial antibody. J Clin Gastroenterol. 2002;34:100-101.
38. Larrey D, Vial T, Pauwels A, Castot A, Biour M, David M, et al. Hepatitis after germander (Teucriumchamaedrys) administration: another instance of herbal medicine hepatotoxicity. Ann Intern Med. 1992;117:129-132.
39. Ben Yahia M, Mavier P, Metreau JM, Zafrani ES, Fabre M, Gatineau-Saillant G, et al. Chronic active hepatitis chronic active hepatitis. Gastroenterol Clin Biol. 1993;17:956-962.
40. Perez Alvarez J, Saez-Royuela F, Gento Pena E, Lopez Morante A, Velasco Oses A, Martin Lorente. J Acute hepatitis due to ingestion of Teucriumchamaedrys infusions. Gastroenterol Hepatol. 2001;24:240-243.
41. De Berardinis V, Moulis C, Maurice M, Beaune P, Pessayre D, Pompon D, et al. Human microsomal pertaining to or emanating from microsome. Mol Pharmacol. 2000;58:542-551.
42. Khleiefat K, Shakhanbeh J, Trawneh K. The chronic effect of Teucrium polium on some blood parameters and histophatology of liver and kidney in rat. Turk J Biol. 2002:26;65-71.
43. Gheissari A, Hemmatzadeh S, Merrikhi A, Fadaei Tehrani S, Madihi Y. chronic kidney disease in children: A report from a tertiary care center over 11 years. J Nephropathology. 2012;1(3):177-182.
44. Markowitz GS, Perazella MA. Drug-induced renal failure: a focus on tubule interstitial disease. Clin Chim Acta. 2005;351:31-47.
45. Gheissari A, Mehrasa P, Merrikhi A, Madihi Y. Acute kidney injury: A pediatric experience over 10 years at a tertiary care center. J Nephropathology. 2012;1(2):101-108.
46. Steele MR, Belostotsky V, Lau KK. The dangers of substance abuse in adolescents with chronic kidney disease: a review of the literature. Cannt J. 2012;22(1):15-22.
47. Assadi F. The epidemic of pediatric chronic kidney disease the danger of skepticism. J Nephropathology. 2012;1(2):61-64.
48. Yoshitomi T, Hirayama A, Nagasaki Y. The ROS scavenging and renal protective effects of pH-responsive nitroxide radicalcontaining nanoparticles. Biomaterials. 2011;32(31):8021-8028.
49. Gheshlaghi F. Malignant drug-induced rhabdomyolysis. J Nephropathology. 2012;1(1):59-60.
50. Nasri H. Sudden onset of acute renal failure requiring dialysis associated with large B-cell lymphoma of colon. J Nephropathology. 2012;1(3):202-206.
51. Tolouian R, Hernandez GT. Prediction of Diabetic Nephropathy: The need for a sweet biomarker. J Nephropathology. 2013;2(1):4-5.
52. Rouhi H, Ganji F. Effect of N-acetyl cysteine on serum Lipoprotein (a) and proteinuria in type 2 diabetic patients. J Nephropathology. 2013;2(1):61-66.
53. Tavafi M. Diabetic nephropathy and antioxidants. J Nephropathology. 2013;2(1):20-27.
54. Craig W, Beck L. Phytochemicals: Health Protective Effects. Can J Diet Pract Res. 1999;60:78-84.
55. Ashrafi F, Haghshenas S, Nematbakhsh M, Nasri H, Talebi A, Eshraghi-Jazi F. The Role of Magnesium Supplementation in Cisplatin-induced Nephrotoxicity in a Rat Model: No Nephroprotectant Effect. Int J Prev Med. 2012;3(9):637-643.
56. Eshraghi-Jazi F, Nematbakhsh M, Nasri H, Talebi A, Haghighi M, Pezeshki Z. The protective role of endogenous nitric oxide donor (L-arginine) in cisplatin-induced nephrotoxicity: Gender related differences in rat model. J Res Med Sci. 2011;16(11):1389-1396.
57. Hemati S, Arbab Jolfaie N, Gookizadeh A, Rafienia M, Ghavamnasiri M. The effects of vitamin E and selenium on cisplatin-induced nephrotoxicity in cancer patients treated with cisplatin-based chemotherapy: A randomized, placebocontrolled study. J Res Med Sci. 2012;17(Spec 1):S49-S58.